Donate and help us develop more life-saving treatments for everyone
Jenny was only 37 when she was diagnosed with advanced melanoma
In 2022, Jenny was diagnosed with melanoma and completed treatment in 2024. Sadly, just four months later, her cancer returned. Finding three tumours, her local hospital asked The Royal Marsden for advice. While Jenny’s tumours were inoperable, she was able to join a ground-breaking clinical trial, TILVANCE- 301.
The trial is using TIL therapy, an innovative immunotherapy treatment that harvests your body’s own immune cells, activates them to better recognise and attack cancer cells and then reintroduces them to the body. Thankfully, the trial is working and Jenny’s tumour has shrunk by more than 40%.
With your support, we can continue developing innovative, personalised treatments for patients everywhere.
“I genuinely believe that this clinical trial is saving my life.”
When Jenny was considering an innovative clinical trial, she met her research nurse, Lauren
Lauren played a vital role in guiding her through the process, ensuring Jenny understood the trial and felt supported throughout. Clinical trials can be complex, and having expert support helped Jenny manage both the treatment and the uncertainty that comes with it.
Jenny says that: “Having someone there who understands both the research and what you’re going through makes all the difference.” From staying late to offer support, to helping Jenny through the toughest moments, Lauren was always there.
“Our main goal is to make sure that patients live a long and amazing life.”
Donate today to help us give more cancer patients a future to look forward to
Cancer rates are set to rise by up to 40% by 2050*, meaning more families than ever will be affected. With your support, The Royal Marsden Cancer Charity can support pioneering research and clinical trials, helping save lives now and in the future.
*Source: JAMA Oncology estimates a 41.7% rise in very high–HDI countries and IARC/WHO data show a predicted 37% increase in the UK.